These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 20727958
61. A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents. Killian DM, Chikhale PJ. J Neurochem; 2001 Feb; 76(4):966-74. PubMed ID: 11181816 [Abstract] [Full Text] [Related]
62. Preparation and Pharmacological Evaluation of Novel Orally Active Ester Prodrugs of Ketoprofen with Non-Ulcerogenic Property. Dhakane VD, Thakare VN, Dongare SB, Bhale PS, Mule YB, Bandgar BP, Chavan HV. Chem Biol Drug Des; 2016 Jun; 87(6):878-84. PubMed ID: 26715009 [Abstract] [Full Text] [Related]
68. Enzyme-catalyzed synthesis of a novel thermosensitive polyester with pendant ketoprofen. Wang HY, Zhou YJ, Wang Z, Wang N, Li K, Yu XQ. Macromol Biosci; 2011 May 12; 11(5):595-9. PubMed ID: 21400661 [Abstract] [Full Text] [Related]
69. Ketoprofen 1-alkylazacycloalkan-2-one esters as dermal prodrugs: in vivo and in vitro evaluations. Bonina F, Santagati NA, Puglia C. Drug Dev Ind Pharm; 2003 Feb 12; 29(2):181-90. PubMed ID: 12648015 [Abstract] [Full Text] [Related]
70. Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system. Killian DM, Hermeling S, Chikhale PJ. Drug Deliv; 2007 Jan 12; 14(1):25-31. PubMed ID: 17107928 [Abstract] [Full Text] [Related]
71. Brain-specific delivery of naproxen using different carrier systems. Mahmoud S, Mohammad A. Arch Pharm (Weinheim); 2010 Nov 12; 343(11-12):639-47. PubMed ID: 21110306 [Abstract] [Full Text] [Related]
72. LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates. Zur AA, Chien HC, Augustyn E, Flint A, Heeren N, Finke K, Hernandez C, Hansen L, Miller S, Lin L, Giacomini KM, Colas C, Schlessinger A, Thomas AA. Bioorg Med Chem Lett; 2016 Oct 15; 26(20):5000-5006. PubMed ID: 27624080 [Abstract] [Full Text] [Related]
80. Targeting of Perforin Inhibitor into the Brain Parenchyma Via a Prodrug Approach Can Decrease Oxidative Stress and Neuroinflammation and Improve Cell Survival. Tampio J, Huttunen J, Montaser A, Huttunen KM. Mol Neurobiol; 2020 Nov 25; 57(11):4563-4577. PubMed ID: 32754897 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]